not tagged
not tagged
['breast']
treatment beyond 5yrs with ai in postmenopausal hr+ve early breast cancer doesn't benefit all patients.some subgroups benefit. both er and pr+ve and positive nodal status (i e higher risk benefits from extended ai) #esmo22 
Consultant Oncology Pharmacist, Airedale NHSFT. Honorary Lecturer @BradfordUni. @BOPA Fellow. Very amateur gardener and brewer.